UBS O'Connor »

Cytokinetics shares owned by UBS O'Connor

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-03-31 $210k 3.0k 70.11

More positions owned by UBS O'Connor

Spirit Aer Comcl (SPR)
Equity Comsh (EQC)
Revance Th Note1 (Principal)
Peloton In Note2 (Principal)
Spirit Air Note1 (Principal)
Ryanair Ho Spons (RYAAY)
3M Company (MMM)
Mattel (MAT)
Parker-Hannifin Corporation (PH)
Fubotv Note3 (Principal)
Teck Resou CLB (TECK)
Constellation Energy (CEG)
Broadcom (AVGO)
Norfolk Southern (NSC)
NVIDIA Corporation (NVDA)

View all positions for UBS O'Connor

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
T. Rowe Price Investment Management
Wellington Management Company
State Street Corporation
Bank of America Corporation
Armistice Capital
T. Rowe Price Associates
Geode Capital Management
Rtw Investments
Polar Capital Holdings
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA

View all funds holding Cytokinetics